These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10508285)

  • 1. Pathophysiologic basis of contrast enhancement in breast tumors.
    Knopp MV; Weiss E; Sinn HP; Mattern J; Junkermann H; Radeleff J; Magener A; Brix G; Delorme S; Zuna I; van Kaick G
    J Magn Reson Imaging; 1999 Sep; 10(3):260-6. PubMed ID: 10508285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of tumor angiogenesis using dynamic enhanced magnetic resonance imaging: comparison of plasma vascular endothelial growth factor, hemodynamic, and pharmacokinetic parameters.
    Ikeda O; Nishimura R; Miyayama H; Yasunaga T; Ozaki Y; Tuji A; Yamashita Y
    Acta Radiol; 2004 Jul; 45(4):446-52. PubMed ID: 15323399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
    Lee AH; Dublin EA; Bobrow LG; Poulsom R
    J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast.
    Guidi AJ; Schnitt SJ; Fischer L; Tognazzi K; Harris JR; Dvorak HF; Brown LF
    Cancer; 1997 Nov; 80(10):1945-53. PubMed ID: 9366297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer.
    Brown LF; Berse B; Jackman RW; Tognazzi K; Guidi AJ; Dvorak HF; Senger DR; Connolly JL; Schnitt SJ
    Hum Pathol; 1995 Jan; 26(1):86-91. PubMed ID: 7821921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.
    Jia WR; Chai WM; Tang L; Wang Y; Fei XC; Han BS; Chen M
    Eur J Radiol; 2014 Jul; 83(7):1098-1105. PubMed ID: 24794865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
    Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
    Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.
    Bhujwalla ZM; Artemov D; Natarajan K; Ackerstaff E; Solaiyappan M
    Neoplasia; 2001; 3(2):143-53. PubMed ID: 11420750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF).
    Cyran CC; Sennino B; Fu Y; Rogut V; Shames DM; Chaopathomkul B; Wendland MF; McDonald DM; Brasch RC; Raatschen HJ
    Eur J Radiol; 2012 May; 81(5):891-6. PubMed ID: 21889860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer.
    Su MY; Cheung YC; Fruehauf JP; Yu H; Nalcioglu O; Mechetner E; Kyshtoobayeva A; Chen SC; Hsueh S; McLaren CE; Wan YL
    J Magn Reson Imaging; 2003 Oct; 18(4):467-77. PubMed ID: 14508784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging measurements of vascular permeability and extracellular volume fraction of breast tumors by dynamic Gd-DTPA-enhanced relaxometry.
    Vincensini D; Dedieu V; Eliat PA; Vincent C; Bailly C; de Certaines J; Joffre F
    Magn Reson Imaging; 2007 Apr; 25(3):293-302. PubMed ID: 17371717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of peripheral enhancement in breast masses: correlation of findings on contrast medium enhanced MRI with histologic features and tumor angiogenesis.
    Buadu LD; Murakami J; Murayama S; Hashiguchi N; Sakai S; Toyoshima S; Masuda K; Kuroki S; Ohno S
    J Comput Assist Tomogr; 1997; 21(3):421-30. PubMed ID: 9135652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours.
    Mussurakis S; Buckley DL; Drew PJ; Fox JN; Carleton PJ; Turnbull LW; Horsman A
    Clin Radiol; 1997 Jul; 52(7):516-26. PubMed ID: 9240704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations.
    Raatschen HJ; Fu Y; Shames DM; Wendland MF; Brasch RC
    Invest Radiol; 2006 Dec; 41(12):860-7. PubMed ID: 17099424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model.
    Tofts PS; Berkowitz B; Schnall MD
    Magn Reson Med; 1995 Apr; 33(4):564-8. PubMed ID: 7776889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging assays for dimethyl sulfoxide effect on cancer vasculature.
    Cyran CC; Sennino B; Chaopathomkul B; Fu Y; Rogut V; Shames DM; Wendland MF; McDonald DM; Brasch RC
    Invest Radiol; 2008 May; 43(5):298-305. PubMed ID: 18424950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival.
    Hawighorst H; Knapstein PG; Knopp MV; Weikel W; Brix G; Zuna I; Schönberg SO; Essig M; Vaupel P; van Kaick G
    Cancer Res; 1998 Aug; 58(16):3598-602. PubMed ID: 9721867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced MRI reveals the extent and the microvascular pattern of breast ductal carcinoma in situ.
    Santamaría G; Velasco M; Farrús B; Caparrós FX; Fernández PL
    Breast J; 2013; 19(4):402-10. PubMed ID: 23758454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.
    Chen W; Giger ML; Bick U; Newstead GM
    Med Phys; 2006 Aug; 33(8):2878-87. PubMed ID: 16964864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.